EurekAlert!

Early IABP use no better than medication in cardiogenic shock due to heart failure

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Medscape

The Intra-aortic Balloon Pump in High-risk Percutaneous Coronary Intervention

The applicability and validity of registry data remains open to debate. When studying a patient cohort that is notoriously difficult to enroll in randomized trials, registry data can certainly add ...
Medscape

Intra-aortic Balloon Pump May Best Inotropes in Decompensated HF

PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
TCTMD

Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients

Continuing the trajectory seen at 30 days and 1 year, the long-term data from the IABP-SHOCK II trial reported today show no survival benefit for intra-aortic balloon pump (IABP) use in acute MI ...
MedPage Today

Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i

Compared with the years 2000-2009, cardiac deaths and case fatalities in U.S. marathon and half-marathon runners have come down significantly. (JAMA) People with zero of five classic cardiovascular ...
News Medical

Study finds no benefit of early IABP use in cardiogenic shock patients

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Nature

Extended follow-up in IABP-SHOCK II shows no reduction in all-cause mortality with IABP

In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
TCTMD

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...
News Medical

Intra-aortic balloon pump support reduces 30-day mortality in postinfarction VSR patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
Healio

Microaxial blood pump confers better outcomes in high-risk PCI vs. IABP

Please provide your email address to receive an email when new articles are posted on . In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump ...
Healio

Hybrid intra-aortic balloon pump recalled

Please provide your email address to receive an email when new articles are posted on . The FDA announced that Maquet Datascope Corp. has recalled a hybrid intra-aortic balloon pump due to a design ...